A methodological approach to the marketing process in the biotechnology-based companies

Industrial Marketing Management

Volumn 33, Issue 5, 2004, Pages 403-418

  Costa, Carla ^a   Fontes, Margarida ^a,b   Heitor, Manuel V ^a  

^a INSTITUTO SUPERIOR TÉCNICO   (Portugal)

^b Inst Nacl de Eng/Tecnol Indust

Author keywords

Biotechnology based companies; Marketing of innovation; Marketing of technology

Indexed keywords

EID: 2542502502     PISSN: 00198501     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.indmarman.2003.08.016     Document Type: Article

References (36)

1. Abell D. Defining the business: The starting point of strategic planning 1980 Prentice-Hall Englewood Cliffs, NJ
2. Autio E. New technology-based firms in innovation networks symplectic and generative impacts Research Policy 26 1997 263-281
3. Brandys P. Growing an international biotechnology company-Some factors to take into account when establishing a European startup Nature Biotechnology 16 1998 5 (Supplement)
4. Cetindamar D. Laage-Hellman J. The dynamics of commercialisation in the biomedical/biotechnology system Paper presented at the Eighth International Joseph A. Schumpeter Society Conference, Manchester 2000
5. Christensen C.M. The innovator's dilemma: When new technologies cause great firms to fail 1997 Harvard Business School Press Boston, MA
6. Costa C. (2001). Development policies for the biotechnology industry in Portugal. MSc dissertation, IST-Instituto Superior Técnico, Lisbon, Portugal. Available: http://in3.dem.ist.utl.pt/master/98files/2thesis.pd
7. D'Amboise G. Muldowney M. Management theory for small business: Attempts and requirements Academy of Management Review 13 2 1988 226-240
8. Dosi G. Technical change and industrial transformation: The theory and an application to the semiconductor industry 1984 Macmillan London
9. EC (2001). The competitiveness of European biotechnology: A case study of innovation. European Competitiveness Report. EC, Luxembourg.
10. Enriquez J. Goldberg R. Transforming life, transforming business: The life sciences revolution Harvard Business Review 2000, March/April 96-104
11. EuropaBio Benchmarking the competitiveness of biotechnology in Europe 1997 EuropaBio Brussels
12. Faulkner W. The new firm phenomenon in biotechnology In Rosa P. Burley S. Cannon T. O'Neill K. (Eds.), The role and contribution of small business research 1989 Gower Aldershot
13. Jones-Evans D. A typology of technology-based entrepreneurs: A model based on previous occupational background International Journal of Entrepreneurial Behaviour and Research 1 1 1995 26-47
14. Kazanjian R.K. Relation of dominant problems to stages of growth in technology based new ventures Academy of Management Journal 31 2 1988 257-279
15. Kotler P. Marketing management-Analysis, planning, implementation and control 7th ed. 1991 Prentice-Hall Englewood Cliffs, NJ, USA
16. Lynn G.S. Morone J.G. Paulson A.S. Marketing and discontinuous innovation: The probe and learn process California Management Review 38 1996 3
17. Mangematin V. Lemarié S. & Catherine D. (2001). Sectoral system of innovation: SMEs development and heterogeneity trajectories. Document de Travail INRA 2001-06.
18. Miles M.B. Huberman A.M. Qualitative data analysis - A sourcebook of new methods 1984 Sage Newbury Park
19. Moore G. Crossing the chasm 1995 HarperBusiness New York
20. Moore G. Inside the tornado 1995 HarperBusiness New York
21. Moriarty R.T. Kosnik T.J. High-tech vs. low-tech marketing: Where's the beef? Note 9-588-012 1987 Harvard Business School Boston, MA
22. Mustar P. Partnerships, configurations and dynamics in the creation and development of SMEs by researchers Industry and Higher Education 1998, August 217-221
23. Nelson R.R. Winter S.G. An evolutionary theory of economic change 1982 Belknap Press of Harvard University Press Cambridge, MA
24. Orsenigo L. The emergence of biotechnology - Institutions, markets and industrial innovation 1989 Printer London
25. Orsenigo L. Start-ups européenes: le déclic? Biofutur 194 1999 (special issue)
26. Pavitt K. (1987). On the nature of technology. Inaugural lecture given at the University of Sussex, June 23, 1987, Brighton, SPRU.
27. Pfirrmann O. Neither soft nor hard - Pattern of development of new technology based firms in biotechnology Technovation 19 1999 651 659
28. Plaut S.E. Ilan Y. The optimal degree of diversification in 'high-tech' firms R&D Management 17 1987 3
29. Rogers E.M. Diffusion of innovations 1962 Free Press New York
30. Sharp M. & Galimberti I. (1993). Coherence and diversity: Europe's chemical giants and the assimilation of biotechnology. STEEP Discussion Paper No. 5. University of Sussex.
31. Sharp M. Senker J. European biotechnology: Learning and catching-up In Gambardella A. & Malerba F. (Eds.), The organization of economic innovation in Europe 1999 269-302 Cambridge University Press Cambridge
32. Storey D.J. Tether B. A Review on the Empirical Knowledge and an Assessment of Statistical Data on the Economic Importance of the New Technology Based Firms in Europe An European Innovation Monitoring Systems (EIMS) Study 1996 University of Warwick Coventry, UK
33. Teece D.J. Profiting from technological innovation: Implications for integration, collaboration, licensing and public policy Research Policy 15 1986 285-305
34. Teece D.J. Technological change and the nature of the firm In Dosi G. et al. (Eds.), Technical change and economic theory 1988 256-281 Frances Printer London
35. Walsh V. Demand, public markets and innovation in biotechnology Science and Public Policy 20 3 1993 138-156
36. Walsh V. Niosi J. Mustar P. Small-firm formation in biotechnology: A comparison of France, Britain and Canada Technovation 15 5 1995 303-327